HIV-1 Episomes and Viral Rebound
Author Information
Author(s): Mark Sharkey, Dunja Z. Babic, Thomas Greenough, Roy Gulick, Daniel R. Kuritzkes, Mario Stevenson
Primary Institution: University of Massachusetts Medical School
Hypothesis
Can analysis of episomal HIV-1 genomes help characterize the virus that persists during antiretroviral therapy and contributes to treatment failure?
Conclusion
The study found that viral rebound after treatment interruption originated from a cryptic viral reservoir identified by episomal sequences.
Supporting Evidence
- Episomal envelope sequences were highly similar to sequences in rebounding virus.
- Viral rebound was linked to a cryptic viral reservoir.
- Episomal sequences predicted treatment failure in patients receiving CCR5 antagonists.
Takeaway
This study shows that even when HIV treatment seems to be working, the virus can hide and come back when treatment stops, and we can find clues about this hidden virus by looking at special pieces of its genetic material.
Methodology
The study analyzed episomal and proviral HIV-1 genomes from six individuals who had suppressed viral replication for at least 20 months before treatment interruption.
Limitations
The study was limited to a small sample size and may not be generalizable to all HIV-1 infected individuals.
Participant Demographics
Participants were HIV-1 infected individuals on antiretroviral therapy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website